CA41892-11A - 0x000000000000646A
Healthy Males & Females
Alloy
* El estipendio puede pagar hasta el monto reflejado.
Start Date:
December 10, 2024 - 2:15pm
End Date:
December 18, 2024 - 9:00am
Study Details
Study Number: CA41892
Group Number: 11A
Study Requirement: Healthy Normal Male and Female
Stipend: up to $3,750.00
Study Criteria
Age: 19 - 55
BMI: 18 - 32
Weight Restriction: minimum weight 0 lbs
Study Information
Indication: This investigational medication is being developed to treat multiple sclerosis.
Route of Administration: Oral
Blood Draws: 20
Study Schedule
Schedule Type: Short stays with returns
Study Length: 4 Night Stay & 1 Return
Screening Dates:
Event Day | Event Date |
---|---|
Tuesday | 12/3/2024 |
Thursday | 12/5/2024 |
Friday | 12/6/2024 |
Monday | 12/9/2024 |
Doctor Exam Dates:
Event Day | Event Date |
---|---|
Tuesday | 12/3/2024 |
Thursday | 12/5/2024 |
Friday | 12/6/2024 |
Monday | 12/9/2024 |
Study Dates:
Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
---|---|---|---|---|---|---|
Check-In | Tuesday | 12/10/2024 2:15:00 PM | Saturday | 12/14/2024 11:15:00 AM | 1 | Lincoln |
Return | Wednesday | 12/18/2024 7:30:00 AM | Wednesday | 12/18/2024 9:00:00 AM | 1 | Lincoln |